LINC02136

Across TCGA pan-cancer cohorts, LINC02136 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC02136 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02136 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02136 expression acts as an unfavorable survival marker, although some lineages such as STAD and KICH show a favorable association.

LIHC, HNSC, and STAD are the cancer types where LINC02136 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.140	0.709	<.001	81	view →
HNSC	OS	Tertile	III,IV	0.151	0.694	<.001	42	view →
STAD	OS	Quartile	IV	0.708	0.209	.002	36	view →
SKCM	DFS	Tertile	All	0.210	0.618	<.001	36	view →
LUAD	OS	Tertile	All	0.546	0.704	.002	36	view →
LUSC	DFS	Tertile	III,IV	0.152	0.781	.004	18	view →
SARC	OS	Tertile	All	0.153	0.529	.001	12	view →
ESCA	DFS	Tertile	II,III,IV	0.131	0.776	.043	9	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
PCPG	DFS	Tertile	All	0.161	0.819	.004	9	view →
KICH	OS	Median	III,IV	1.000	0.804	.028	7	view →
MESO	DFS	Quartile	II,III,IV	0.266	0.399	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC02136–LIHC (OS)

Open the LIHC breakdown →